Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Dudley et al. (Mon,) studied this question.

www.synapsesocial.com/papers/69e68f2156489ac743ff1b9b — DOI: https://doi.org/10.1200/jco.2008.16.5449

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance· 2004 · 364 citations
2. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling· 2007 · 19 citations
3. Guidelines for the Safe Administration of High-Dose Interleukin-2· 2001 · 178 citations
4. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials· 1987 · 362 citations
5. Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma· 2005 · 1,627 citations